feed,title,long_url,short_url
MedRxiv,"An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-beta-1a and hydroxychloroquine in hospitalized patients with COVID-19 - Final results from the DisCoVeRy trial",https://medrxiv.org/cgi/content/short/2022.02.16.22271064v1?rss=1,https://bit.ly/350OFv3
MedRxiv,SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway,https://medrxiv.org/cgi/content/short/2022.02.16.22271075v1?rss=1,https://bit.ly/3I8E1kd
